FBC
QGENF

Fairfield, Bush & Co’s QIAGEN NV QGENF Stock Holding History

Fairfield, Bush & Co’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-148
Closed -$3K – 300
2013
Q3 		$3K Hold
148
– – ﹤0.01% 290
2013
Q2 		$3K Buy
+148
New +$3K ﹤0.01% 277

Other funds holding QGENF

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Fairfield, Bush & Co's QGENF Position: Q4 2013 in Review

Fairfield, Bush & Co sold out of QIAGEN NV (QGENF) in Q4 2013, closing a stake of 148 shares — an estimated $3K sold.

Fairfield, Bush & Co first reported a position in QGENF in Q2 2013 and held it in 2 quarters. The position peaked at $3K in Q3 2013. 165 funds tracked by Wall St. Rank hold QGENF as of Q4 2013.

  • Fairfield, Bush & Co reported no remaining QIAGEN NV position as of Q4 2013 after selling out during the quarter.
  • Fairfield, Bush & Co sold 148 QIAGEN NV shares in Q4 2013, an estimated $3K.
  • Fairfield, Bush & Co first reported a position in QIAGEN NV in Q2 2013 and held it in 2 quarters.
  • Fairfield, Bush & Co's QIAGEN NV position peaked at $3K in Q3 2013.
  • 165 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2013.

Based on Fairfield, Bush & Co's 13F filing for Q4 2013, filed 14 Feb 2014.